A citation-based method for searching scientific literature

P A van Luijt, E A M Heijnsdijk, J Fracheboud, L I H Overbeek, M J M Broeders, J Wesseling, G J den Heeten, H J de Koning. Breast Cancer Res 2016
Times Cited: 41







List of co-cited articles
184 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
185
29

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
196
26

Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.
Yasuaki Sagara, Melissa Anne Mallory, Stephanie Wong, Fatih Aydogan, Stephen DeSantis, William T Barry, Mehra Golshan. JAMA Surg 2015
109
21

Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Stephen W Duffy, Amanda Dibden, Dimitrios Michalopoulos, Judith Offman, Dharmishta Parmar, Jacquie Jenkins, Beverley Collins, Tony Robson, Suzanne Scorfield, Kathryn Green,[...]. Lancet Oncol 2016
76
17


Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.
M-F Yen, L Tabár, B Vitak, R A Smith, H-H Chen, S W Duffy. Eur J Cancer 2003
99
17

Ductal carcinoma in situ: a proposal for a new classification.
R Holland, J L Peterse, R R Millis, V Eusebi, D Faverly, M J van de Vijver, B Zafrani. Semin Diagn Pathol 1994
436
14

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
388
14

Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis.
Marc D Ryser, Mathias Worni, Elizabeth L Turner, Jeffrey R Marks, Rick Durrett, E Shelley Hwang. J Natl Cancer Inst 2015
38
15

Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive.
M Casparie, A T M G Tiebosch, G Burger, H Blauwgeers, A van de Pol, J H J M van Krieken, G A Meijer. Cell Oncol 2007
556
12

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
Lotte E Elshof, Michael Schaapveld, Marjanka K Schmidt, Emiel J Rutgers, Flora E van Leeuwen, Jelle Wesseling. Breast Cancer Res Treat 2016
35
14

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
225
12

The natural history of ductal carcinoma in situ of the breast: a review.
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig. Breast Cancer Res Treat 2006
214
12

Treatment of low-risk ductal carcinoma in situ: is nothing better than something?
John R Benson, Ismail Jatoi, Masakazu Toi. Lancet Oncol 2016
43
12

Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Emma J Groen, Lotte E Elshof, Lindy L Visser, Emiel J Th Rutgers, Hillegonda A O Winter-Warnars, Esther H Lips, Jelle Wesseling. Breast 2017
77
12


Characterizing the impact of 25 years of DCIS treatment.
Elissa M Ozanne, Yiwey Shieh, James Barnes, Colleen Bouzan, E Shelley Hwang, Laura J Esserman. Breast Cancer Res Treat 2011
71
12

Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data.
Arnaud Seigneurin, Olivier François, José Labarère, Pierre Oudeville, Jean Monlong, Marc Colonna. BMJ 2011
34
14

Interpreting overdiagnosis estimates in population-based mammography screening.
Rianne de Gelder, Eveline A M Heijnsdijk, Nicolien T van Ravesteyn, Jacques Fracheboud, Gerrit Draisma, Harry J de Koning. Epidemiol Rev 2011
135
12

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
325
9

Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study.
Adriana M J Bluekens, Roland Holland, Nico Karssemeijer, Mireille J M Broeders, Gerard J den Heeten. Radiology 2012
88
9


Epidemiology of ductal carcinoma in situ.
Karla Kerlikowske. J Natl Cancer Inst Monogr 2010
124
9

Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
H Gilbert Welch, Philip C Prorok, A James O'Malley, Barnett S Kramer. N Engl J Med 2016
301
9

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
372
9

Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?
Stefanie Weigel, Hans W Hense, Jan Heidrich, Shoma Berkemeyer, Walter Heindel, Oliver Heidinger. Radiology 2016
13
30

Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
László Tabár, Bedrich Vitak, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Anders Cohen, Tibor Tot, Sherry Yueh-Hsia Chiu, Sam Li-Sheng Chen, Jean Ching-Yuan Fann, Johan Rosell,[...]. Radiology 2011
412
9


Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
173
9

Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data.
Harry J de Koning, Gerrit Draisma, Jacques Fracheboud, Arry de Bruijn. Breast Cancer Res 2006
32
12

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Jeanne S Mandelblatt, Natasha K Stout, Clyde B Schechter, Jeroen J van den Broek, Diana L Miglioretti, Martin Krapcho, Amy Trentham-Dietz, Diego Munoz, Sandra J Lee, Donald A Berry,[...]. Ann Intern Med 2016
143
9


Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches.
Nicolien T van Ravesteyn, Jeroen J van den Broek, Xiaoxue Li, Harald Weedon-Fekjær, Clyde B Schechter, Oguzhan Alagoz, Xuelin Huang, Donald L Weaver, Elizabeth S Burnside, Rinaa S Punglia,[...]. Med Decis Making 2018
14
28

Digital mammography screening: weighing reduced mortality against increased overdiagnosis.
Rianne de Gelder, Jacques Fracheboud, Eveline A M Heijnsdijk, Gerard den Heeten, André L M Verbeek, Mireille J M Broeders, Gerrit Draisma, Harry J de Koning. Prev Med 2011
42
9

Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands.
Carmen van Dooijeweert, Paul J van Diest, Stefan M Willems, Chantal C H J Kuijpers, Lucy I H Overbeek, Ivette A G Deckers. Breast Cancer Res Treat 2019
20
20

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
E Shelley Hwang, Terry Hyslop, Thomas Lynch, Elizabeth Frank, Donna Pinto, Desiree Basila, Deborah Collyar, Antonia Bennett, Celia Kaplan, Shoshana Rosenberg,[...]. BMJ Open 2019
98
9


The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
487
7

Breast Cancer Screening, Incidence, and Mortality Across US Counties.
Charles Harding, Francesco Pompei, Dmitriy Burmistrov, H Gilbert Welch, Rediet Abebe, Richard Wilson. JAMA Intern Med 2015
120
7

Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review.
Nereo Segnan, Silvia Minozzi, Paola Armaroli, Michela Cinquini, Cristina Bellisario, Marien González-Lorenzo, Silvia Gianola, Antonio Ponti. Int J Cancer 2016
8
37


Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
444
7

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
323
7

Long-term follow-up of in situ carcinoma of the breast.
V Eusebi, E Feudale, M P Foschini, A Micheli, A Conti, C Riva, S Di Palma, F Rilke. Semin Diagn Pathol 1994
215
7

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
232
7

Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
Yasuaki Sagara, Rachel A Freedman, Ines Vaz-Luis, Melissa Anne Mallory, Stephanie M Wong, Fatih Aydogan, Stephen DeSantis, William T Barry, Mehra Golshan. J Clin Oncol 2016
84
7

Rethinking the Standard for Ductal Carcinoma In Situ Treatment.
Laura Esserman, Christina Yau. JAMA Oncol 2015
66
7


Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
Stephen W Duffy, Olorunsola Agbaje, Laszlo Tabar, Bedrich Vitak, Nils Bjurstam, Lena Björneld, Jonathan P Myles, Jane Warwick. Breast Cancer Res 2005
130
7

Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.
Stacey K Mardekian, Alessandro Bombonati, Juan P Palazzo. Hum Pathol 2016
31
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.